“We find, curate and progress novel cancer therapeutics.”
– Oncology One CEO, Dr Joanne Boag

Oncology One has united highly skilled and respected leaders in the biotechnology sector, to raise and deploy meaningful capital to progress small molecule cancer drug development programs towards the clinic. We are working to curate and develop high quality programs that aim to meet unmet clinical needs, inclusive of underserved areas such as paediatric and rare cancers.


Oncology One has attracted world-leading experts in medical research, clinical practice and commercialisation. We are a lean, hard-working team, supported by our Scientific Advisory Board that live and breathe oncology innovation across the globe. We are curious and tenacious in our efforts to find and progress projects that can positively impact the lives of people with cancer.

Dr Ian Street

 Chair of Scientific Advisory Board

Professor Mike Waring

Scientific Advisory Board




+61 3 9117 0254

305 Grattan Street, Melbourne, VIC 3000 Australia



Dr Joanne Boag has more than 15 years experience working in the life sciences sector developing health and medical research products and services. Most recently, as Director of Business Development at a commercial stage digital health company, Joanne was responsible for driving execution of the company’s business partnering strategy and supporting all aspects of upstream business development and downstream service delivery.

Previously, Joanne has worked at an ASX-listed diagnostic company and medical research institutions, where she led successful outcomes in research innovation and commercialisation. She raised significant funding through equity financing and grants, facilitated collaborations with industry partners, and was responsible for the strategic management of intellectual property portfolios.

Joanne is a Registered Australian Patent and Trade Mark Attorney and has a Bachelor of Science with Honours from Murdoch University and a PhD in molecular biology from the University of Western Australia.

Michael Vovos has been working in intellectual property management and commercialisation for over 23 years His career has included working with universities, institutes, joint ventures and biotechnology companies. 

Michael has been involved with the creation of technology spin-out companies, numerous licensing opportunities and technology transfer transactions.

Notable career achievements include involvement in several R&D syndicates that bought in millions of dollars of research funding, the creation of a start-up company that manufactured bio-degradable plastics, and numerous license transactions – one that brought in $20 million dollar up-front payments. 

In addition Michael has worked with the Food and Packaging CRC, worked to establish the Innovative Dairy Products CRC and was involved in the establishment of the CRC for Mental Health.

Tim Murphy has held a number of non-executive director positions including Chair, Deputy Chair and numerous subcommittee role in sectors from youth support to indigenous affairs, insurance, clinical trial management, medical research and healthcare delivery.

He is a politically astute executive, with extensive experience working with C-suite executives to manage corporate issues in regulated environments. He has extensive experience in high-growth, merger, consolidation, and downsizing global and national business environments.

Tim is a Fellow of the Australian Institute of Company Directors and in 2011 was awarded Lifetime membership of BioMelbourne Network for his contribution to its inception and development.

Mary Harney is a cross sectoral specialist with three decades of board, company secretarial and C-Suite executive experience in the health, agricultural, pharmaceutical and biotechnology sectors. She is a Non-executive Director of ASX listed Race Oncology (ASX:RAC).

Mary is the director of specialist consulting firm - Mary Harney Advisory - providing leadership, governance and strategic advice across industries such as health and biotech. She is a business builder and convergence specialist with a proven ability to connect innovative ideas and people.

Mary is the Monash University 2016 ‘Science Alumni of the Year’ and the 2015 B-HERT Awardee for Excellence in Collaboration - industry and academia - with Monash University. She is a Member of the Australian Institute of Company Directors and a Fellow of the Australian Institute of Managers and Leaders.